课题基金 / 基金详情

CHARACTERIZATION OF MAMMALIAN ADP-RIBOSLYTRANSFERASES

CHARACTERIZATION OF MAMMALIAN ADP-RIBOSLYTRANSFERASES
哺乳动物 ADP-核糖转移酶的表征
批准号:
2576748
负责人:
J MOSS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

J MOSS的其他基金

相似基金

相关文献

中文摘要
翻译
单adp核糖基化,蛋白质的翻译后修饰
英文摘要
Mono-ADP-ribosylation, a posttranslational modification of proteins in which the ADP-ribose moiety of NAD is transferred to proteins, is responsible for the toxicity of some bacterial toxins (e.g., cholera toxin, pertussis toxin). NAD:arginine ADP-ribosyltransferases cloned from human and rabbit skeletal muscle and from mouse lymphoma cells (Yac- 1 ADP-ribosyltransferase), are glycosylphosphatidylinositol (GPI)- anchored and have similar enzymatic and physical properties. A second ADP-ribosyltransferase (Yac-2) was cloned from mouse lymphoma cells, which differs in properties from the previously identified eukaryotic transferases. The nucleotide and deduced amino acid sequences of the Yac-1 and Yac-2 transferases are 58 and 33% identical, respectively. The Yac-2 protein is membrane-bound but, unlike the Yac-1 enzyme, appears not to be GPI-anchored. The Yac-1 and Yac-2 enzymes, expressed as glutathione-S-transferase fusion proteins in E. coli, were used to compare their ADP-ribosyltransferase and NAD glycohydrolase activities. Using agmatine as the ADP-ribose acceptor, the Yac-1 enzyme was predominantly an ADP-ribosyltransferase, whereas the transferase and NAD glycohydrolase activities of the recombinant Yac-2 protein were similar. The deduced amino acid sequence of the Yac-2 transferase contained consensus regions common to several bacterial toxin and mammalian transferases and NAD glycohydrolases, consistent with the hypothesis that there is a common mechanism of NAD binding and catalysis among ADP- ribosyltransferases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
ROLE OF NITRIC OXIDE IN THE PATHOGENESIS OF LUNG DISEASE
ADP-RIBOSYLATION CYCLES
海外基金